Premier, Inc. (NASDAQ: PINC) announced that its stockholders have overwhelmingly approved the proposed acquisition by an affiliate of Patient Square Capital. The approval, recorded at a special meeting held on November 21, 2025, confirms a $2.6 billion cash transaction that will be completed once regulatory and shareholder approvals are finalized. The deal values Premier at $28.25 per share, a 23.8% premium to the 60‑day volume‑weighted average price as of September 5, 2025.
Continue reading for full analysis...